In focus · trending topic

JubilantPharma

1 stories · following the connections

Jubilant DraxImage receives approval for new pulmonary indications from the U.S. Food and Drug Administration for DRAXIMAGE® DTPA

By Nasdaq OMXJan 2, 2018, 3:45 PM UTC